TrendingVideosIndia
Opinions | CommentEditorialsThe MiddleLetters to the EditorReflections
UPSC | Exam ScheduleExam Mentor
State | Himachal PradeshPunjabJammu & KashmirHaryanaChhattisgarhMadhya PradeshRajasthanUttarakhandUttar Pradesh
City | ChandigarhAmritsarJalandharLudhianaDelhiPatialaBathindaShaharnama
World | ChinaUnited StatesPakistan
Diaspora
Features | The Tribune ScienceTime CapsuleSpectrumIn-DepthTravelFood
Business | My MoneyAutoZone
News Columns | Straight DriveCanada CallingLondon LetterKashmir AngleJammu JournalInside the CapitalHimachal CallingHill View
Don't Miss
Advertisement

British sprinter Chijindu Ujah gets 22-month ban for doping violation

Unlock Exclusive Insights with The Tribune Premium

Take your experience further with Premium access. Thought-provoking Opinions, Expert Analysis, In-depth Insights and other Member Only Benefits
Yearly Premium ₹999 ₹349/Year
Yearly Premium $49 $24.99/Year
Advertisement

October 10

Advertisement

British sprinter Chijindu Ujah has been banned for 22 months for a doping violation at last year’s Tokyo Olympics, the Athletics Integrity Unit (AIU) said on Monday.

Advertisement

Ujah had been provisionally suspended after Ostarine and S-23 — substances prohibited by world anti-doping organisation WADA — were detected in his A and B samples following the men’s 4x100m relay final in which Britain finished second behind Italy.

The AIU, which oversees integrity issues in international athletics, including doping, said Ujah’s ban was effective August 6 2021 and will be in force until June 5, 2023.

Ujah, 28, and his team mates Zharnel Hughes, Richard Kilty and Nethaneel Mitchell-Blake were stripped of their silver medal in February after a Court of Arbitration for Sport ruling. Canada were upgraded to silver and China to bronze.

Advertisement

The sprinter had said he had “not knowingly or intentionally doped” but Kilty said in February British Athletics and UK Anti-Doping had “hammered home” their rules, asking athletes not to use uncertified supplements. Reuters

Advertisement
Show comments
Advertisement